OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Bazhenova on Ongoing Clinical Trials With Immunotherapy in NSCLC

May 28th 2020

Lyudmila A. Bazhenova, MD, discusses ongoing clinical trials in non–small cell lung cancer that are investigating the utility of immunotherapy.

Dr. Brody on Addressing Acquired Resistance to Immunotherapy in Non-Hodgkin Lymphoma

May 28th 2020

Joshua Brody, MD, discusses addressing required resistance to immunotherapy in non-Hodgkin lymphoma.

Dr. Otterson on the Utility of Immunotherapy in NSCLC

May 28th 2020

Gregory A. Otterson, MD, discusses data examining immunotherapy alone versus in combination in non–small cell lung cancer.

Dr. Bertino on the Impact of the EGFR-Mutated Subset Analysis of IMpower150 in NSCLC

May 27th 2020

Erin M. Bertino, MD, discusses the impact of the EGFR-mutated subset analysis of the phase 3 IMpower150 trial on the use of immunotherapy in patients with non–small cell lung cancer.

Dr. Brammer on Data With Inotuzumab Ozogamicin in ALL

May 27th 2020

Jonathan E. Brammer, MD, discusses data that have been reported with inotuzumab ozogamicin (Besponsa) in acute lymphoblastic leukemia (ALL).

Dr. Mims on the Beat AML Master Trial in AML

May 27th 2020

Alice S. Mims, MD, discusses the Beat AML Master Trial in acute myeloid leukemia (AML).

Dr. Kaplan on Research With Bispecific Monoclonal Antibodies in Follicular Lymphoma

May 27th 2020

Lawrence D. Kaplan, MD, discusses research with bispecific monoclonal antibodies in follicular lymphoma.

Dr. Rosenberg on the KEYNOTE-045 Trial in Advanced Urothelial Cancer

May 27th 2020

Jonathan E. Rosenberg, MD, discusses the phase 3 KEYNOTE-045 trial in advanced urothelial cancer.

Dr. Smaglo on the Role of Immunotherapy in Advanced Gastric Cancer

May 27th 2020

Brandon G. Smaglo, MD, FACP, discusses the role of immunotherapy in advanced gastric cancer.

Dr. Le on Research Needed to Address Unmet Needs in mCRC

May 27th 2020

Phat Le, MD, discusses research efforts that are needed to address unmet needs in metastatic colorectal cancer.

Dr. Raghav on the Utility of ctDNA in CRC

May 27th 2020

Kanwal Raghav, MBBS, MD, discusses the utility of circulating tumor DNA in colorectal cancer.

Dr. Savvides on the Risk of COVID-19 in Patients With Cancer

May 27th 2020

Panayiotis S. Savvides, MD, discusses COVID-19 precautions for patients with lung cancer.

Dr. Altomare on Investigational Agents in ITP

May 23rd 2020

Ivy P. Altomare, MD, discusses investigational agents in immune thrombocytopenia.

Dr. Radich on Measuring MRD in Hematologic Malignancies

May 23rd 2020

Jerald P. Radich, MD, discusses measuring minimal residual disease (MRD) in hematologic malignancies.

Dr. Thawani on AEs With Radiation Versus COVID-19 Symptoms in Lung Cancer

May 23rd 2020

Nitika Thawani, MD, discusses identifying the difference between adverse events that are associated with radiation versus COVID-19 symptoms in lung cancer.

Dr. Jain on Next Steps for Venetoclax in Relapsed MCL

May 22nd 2020

Preetesh Jain, MD, PhD, discusses the next steps for a study examining the efficacy of venetoclax in high risk relapsed mantle cell lymphoma.

Dr. Harding on Exciting Research Efforts in the Pipeline for HCC

May 22nd 2020

James J. Harding, MD, exciting research efforts being made in hepatocellular carcinoma.

Dr. Dimou on Managing Disease Progression in NSCLC

May 22nd 2020

Anastasios (Tassos) Dimou, MD, shares advice from managing patients with non–small cell lung cancer who experience disease progression following therapy.

Dr. Sznol on the Use of Immunotherapy in Melanoma

May 22nd 2020

Mario Sznol, MD, discusses the use of immunotherapy in melanoma.

Dr. Smith on Unmet Clinical Needs in Indolent Lymphomas

May 22nd 2020

Sonali M. Smith, MD, discusses unmet clinical needs in indolent lymphomas.